Tradestie Institutional Equity Comparison Engine

OABI vs MXCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MXCT Overall Edge

MXCT Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Options & Structure while OABI counters with relative strength in Momentum & Technical. Fundamentally, OABI trades at N/M Forward P/E with -92.9% operating margin (+78.3% YoY revenue) versus MXCT at N/M Forward P/E and -85.5% operating margin (+48.7% YoY). In options structure, OABI sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro) against MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
OABI N/M vs MXCT N/M Fwd P/E
Growth & Margin Winner MXCT
Op Margin -92.9% vs -85.5% ยท YoY +78.3% vs +48.7%
Momentum & Technical Winner OABI
1Y +182.4% vs -19.4% ยท 52W Pos 81% vs 63%
Options & Structure Winner MXCT
CONSOLIDATION (14th %ile IV) vs UNCLASSIFIED (N/A IV)
OABI NASDAQ
OmniAb, Inc. Common Stock
Services-Commercial Physical & Biological Research
$4.66
-7.36% 1D
Market Cap $733.7M
1M Return -2.51%
1Y Return +182.42%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 15.0 Fund 40.0 Flow 58.0 Mom 40.0
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OABI +182.42% MXCT -19.41% Spread: +201.83 pp (OABI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period OABI Revenue MXCT Revenue OABI Op. Margin MXCT Op. Margin Margin Edge
FY2019 N/A $10M N/A -93.7% MXCT
FY2020 N/A $20M N/A -71.6% MXCT
FY2021 $30M $20M -102.5% -84.3% MXCT
FY2022 $60M $30M -45.1% -95.2% OABI
FY2023 $30M $20M -203.2% -247.7% OABI
FY2024 $30M $20M -282.3% -230.5% MXCT
FY2025 $20M $20M -369.5% -247.6% MXCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OABI (6) vs MXCT (2)
Institutional Metric OABI MXCT Criterion Row Winner
Market Capitalization Scale $733.7M $132.2M Larger Scale OABI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +78.3% +48.7% Higher Growth OABI
Operating Margin (TTM) Profitability -92.9% -85.5% Higher Margin MXCT
Net Profit Margin Profitability -108.1% -81.4% Higher Margin MXCT
Return on Equity (ROE) Capital Efficiency -16.5% -16.9% Higher ROE OABI
52-Week Range Position Momentum 81% ($1โ€“$5) 63% ($1โ€“$2) Stronger Trend OABI
Beta / 30D Volatility Risk Regime 1.24ฮฒ ยท 60% Vol 1.19ฮฒ ยท 96% Vol Lower Realized Risk OABI
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite OABI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OABI vs MXCT Buy Guide
OABI CONSOLIDATION
17d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live OABI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OABI nor MXCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.